Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate
In this article we are going to estimate the intrinsic value of Biocon Limited ( NSE:BIOCON ) by taking the expected...
Indian (NIFTY) Biotech Industry Analysis
UpdatedMay 28, 2022
DataAggregated Company Financials
Companies9
- 7D-2.4%
- 3M-15.2%
- 1Y-14.9%
- YTD-9.8%
Over the last 7 days, the Biotech industry has dropped 2.4%, driven by Biocon declining 2.1%. Overall the industry is down 15% in 12 months. As for the next few years, earnings are expected to grow by 38% per annum.
Industry Valuation and Performance
Has the Indian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Sun, 29 May 2022 | ₹434.8b | ₹92.0b | ₹17.7b | 47.5x |
| Tue, 26 Apr 2022 | ₹486.8b | ₹79.4b | ₹7.0b | 51.9x |
| Thu, 24 Mar 2022 | ₹435.1b | ₹79.4b | ₹7.0b | 55.7x |
| Sat, 19 Feb 2022 | ₹501.6b | ₹79.4b | ₹7.0b | 58.9x |
| Mon, 17 Jan 2022 | ₹463.3b | ₹76.2b | ₹6.9b | 63.4x |
| Wed, 15 Dec 2021 | ₹488.8b | ₹76.2b | ₹6.9b | 61.9x |
| Fri, 12 Nov 2021 | ₹438.4b | ₹76.2b | ₹6.8b | 46.5x |
| Sun, 10 Oct 2021 | ₹453.9b | ₹75.2b | ₹7.1b | 62.3x |
| Tue, 07 Sep 2021 | ₹450.2b | ₹75.2b | ₹7.1b | 61.9x |
| Thu, 05 Aug 2021 | ₹483.6b | ₹75.2b | ₹7.1b | 66.7x |
| Sun, 09 May 2021 | ₹474.3b | ₹74.3b | ₹7.6b | 57.5x |
| Wed, 10 Feb 2021 | ₹460.5b | ₹72.0b | ₹6.1b | 73.5x |
| Tue, 03 Nov 2020 | ₹496.9b | ₹70.7b | ₹6.5b | 52.1x |
| Fri, 07 Aug 2020 | ₹513.2b | ₹74.2b | ₹5.1b | 42.3x |
| Thu, 30 Apr 2020 | ₹442.9b | ₹71.3b | ₹6.1b | 27.4x |
| Sun, 02 Feb 2020 | ₹372.7b | ₹72.0b | ₹9.3b | 34.4x |
| Wed, 06 Nov 2019 | ₹316.1b | ₹69.0b | ₹9.5b | 32.5x |
| Sat, 10 Aug 2019 | ₹290.1b | ₹66.4b | ₹10.7b | 27x |
Median PE Ratio
31.5x
Current Industry PE
- Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 48.2x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have grown 22% per year over the last three years.
- Revenues for these companies have grown 14% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Indian Biotech compare with similar industries?
| IN Market | -0.87% | |
| Healthcare | -1.99% | |
| Biotech | -2.36% | |
| Biotech | -2.36% | |
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 532039 Zenotech Laboratories | ₹56.90 | 3.5% +₹119.0m | 37.1% | PS15.7x |